CVR 40056173Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)København ØFounded 23 Nov 2018
Employees
54
CVR registry, Aug 2026
-3 (-5.3%) over 12 months
Gross profit
5.3M
DKK, annual report 2026
-19.6% on 2025
Result
-42.6M
DKK, annual report 2026
Equity
75.5M
DKK, annual report 2026
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Reshape ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexReshape Biotech Inc.100% of capital and votes, since 4 Mar 2021
Magnus Nyborg Madsensince 23 Nov 2018
Daniel Storgaardsince 23 Nov 2018
Carl-Emil Grøn Fuglesangsince 9 Sep 2019
100% of capital and votessince 4 Mar 2021
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 332437315% to under 10% of capital and votes25 May 2020 to 4 Mar 2021
CVR 4002625825% to under 33.3% of capital and votes23 Nov 2018 to 4 Mar 2021
CVR 4002656825% to under 33.3% of capital and votes23 Nov 2018 to 4 Mar 2021
CVR 4042740625% to under 33.3% of capital and votes23 Aug 2019 to 4 Mar 2021
CVR records founders at incorporation. It does not record whether they are alive or still involved.
23 Nov 2018 to 3 Nov 2026.
20 Mar 2020 to 3 Nov 2026.
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Gross profit | -118 | 1,969 | 1,729 | 6,603 | 5,311 |
| Operating profit | -2,328 | Not reported | Not reported | Not reported | Not reported |
| Result for the year | -1,649 | -4,639 | -12,222 | -35,558 | -42,644 |
| Equity | 5,534 | 26,894 | 25,058 | 36,563 | 75,515 |
| Total assets | 6,140 | 28,220 | 28,632 | 43,713 | 87,778 |
| Employees (average) | 16 | 10 | 18 | 51 | 56 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | -119.9% | 108.8% | -12.2% | 281.9% | -19.6% |
| EBITDA | Not reportednote 1 | Not reportednote 1 | -12,030note 2 | -32,248note 2 | -36,437note 2 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) | n.m.note 3 | Not reportednote 1 | -695.8%note 2 | -488.4%note 2 | -686.1%note 2 |
| Employee growth (vækst i antal ansatte) | 128.6% | -37.5% | 80% | 183.3% | 9.8% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -1,439note 4 | -18,158note 4 | -9,711note 4 | -1,716note 4 | -27,165note 4 |
| ROIC (afkast af investeret kapital) | -73%note 5 | -61.7%note 6 | -80.5%note 6 | -110.1%note 6 | -79.4%note 6 |
| Capex (investeringer i anlægsaktiver) | Not reportednote 7 | Not reportednote 7 | 7,068note 8 | 41,857note 9 | 17,537note 9 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | -1,439note 4 | -18,158note 4 | -9,711note 4 | -6,723note 4 | -32,767note 4 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2026
1 Apr 2025 to 31 Mar 2026, published 15 Jul 2026
Annual report 2025
1 Apr 2024 to 31 Mar 2025, published 2 Oct 2025
Annual report 2024
1 Apr 2023 to 31 Mar 2024, published 3 Jul 2024
Annual report 2023
1 Apr 2022 to 31 Mar 2023, published 21 Jun 2023
Annual report 2022
1 Apr 2021 to 31 Mar 2022, published 30 Jun 2022
1 registered in CVR.
P-number 1024171783Østbanegade 55, 2100 København Ø
